These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30548089)

  • 21. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
    Gori M; Lam CS; Gupta DK; Santos AB; Cheng S; Shah AM; Claggett B; Zile MR; Kraigher-Krainer E; Pieske B; Voors AA; Packer M; Bransford T; Lefkowitz M; McMurray JJ; Solomon SD;
    Eur J Heart Fail; 2014 May; 16(5):535-42. PubMed ID: 24574260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia.
    Lawson CA; Tay WT; Bernhardt L; Richards AM; Zaccardi F; Tromp J; Katherine Teng TH; Hung CL; Chandramouli C; Wander GS; Ouwerkerk W; Seidu S; Khunti K; Lam CSP;
    JACC Asia; 2023 Aug; 3(4):611-621. PubMed ID: 37614542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
    Kristensen SL; Mogensen UM; Jhund PS; Petrie MC; Preiss D; Win S; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Gottdiener JS; Carson PE; McMurray JJ
    Circulation; 2017 Feb; 135(8):724-735. PubMed ID: 28052977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis.
    Kodama S; Fujihara K; Horikawa C; Sato T; Iwanaga M; Yamada T; Kato K; Watanabe K; Shimano H; Izumi T; Sone H
    ESC Heart Fail; 2020 Oct; 7(5):2146-2174. PubMed ID: 32725969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease.
    Khan H; Anker SD; Januzzi JL; McGuire DK; Sattar N; Woerle HJ; Butler J
    J Card Fail; 2019 Feb; 25(2):78-86. PubMed ID: 30423457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.
    Tan ESJ; Tay WT; Teng TK; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton RW; Ling LH; Richards AM; Doughty RN; Lam CSP
    Heart; 2019 Jun; 105(11):842-847. PubMed ID: 30661038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison.
    Arnold SV; Yap J; Lam CSP; Tang F; Tay WT; Teng THK; McGuire DK; Januzzi JL; Fonarow GC; Masoudi FA; Kosiborod M
    Diabetes Obes Metab; 2019 Feb; 21(2):261-266. PubMed ID: 30136348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-specific acute heart failure phenotypes and outcomes from PROTECT.
    Meyer S; van der Meer P; Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Davison BA; Cleland JG; Givertz MM; Bloomfield DM; Fiuzat M; Dittrich HC; Hillege HL; Voors AA
    Eur J Heart Fail; 2013 Dec; 15(12):1374-81. PubMed ID: 24259042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial).
    Vaduganathan M; Dei Cas A; Mentz RJ; Greene SJ; Khan S; Subacius HP; Chioncel O; Maggioni AP; Konstam MA; Senni M; Fonarow GC; Butler J; Gheorghiade M;
    Am J Cardiol; 2014 Sep; 114(5):743-50. PubMed ID: 25060414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
    Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
    Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal trends in risk profiles among patients hospitalized for heart failure.
    Hamo CE; Fonarow GC; Greene SJ; Vaduganathan M; Yancy CW; Heidenreich P; Lu D; Matsouaka RA; DeVore AD; Butler J
    Am Heart J; 2021 Feb; 232():154-163. PubMed ID: 33264607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure.
    Bank IEM; Gijsberts CM; Teng TK; Benson L; Sim D; Yeo PSD; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Richards AM; de Kleijn DPV; Dahlström U; Lund LH; Lam CSP
    JACC Heart Fail; 2017 Jan; 5(1):14-24. PubMed ID: 28447583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Greenberg BH; Abraham WT; Albert NM; Chiswell K; Clare R; Stough WG; Gheorghiade M; O'Connor CM; Sun JL; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):277.e1-8. PubMed ID: 17643576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.